(Q73175626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

M L Disis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K L Knutson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Schiffman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Rinn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D G McNeel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

245-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072789%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006438507898

1 November 2019

exact match

0 references

cites work

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Shared T cell epitopes in epithelial tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by human cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

A population-based serologic survey of immunity to tetanus in the United States

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006438507898

7 January 2021